Skip to content
Screener

Tempus AI, Inc. TEM Stock-Based Comp

Stock-Based Comp at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$6.5M-31.6%
NeoGenomics logo
NeoGenomicsNEO
$8.22M-32.7%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$820K-21.1%
IQVIA logo
IQVIAIQV
$95M+58.3%
Guardant Health logo
Guardant HealthGH
$47.61M+26.1%
Natera, Inc. logo
Natera, Inc.NTRA
$95.11M+22.2%

Other financials

Income statement

See full
Revenue$382.5M+21.6%
Operating income-$75.9M-22.9%
Net income$5.6M+113%
EPS (diluted)$0.03+112%

Balance sheet

See full
Cash & equivalents$599.6M+219%
Total debt$83.5M+51.1%
Total equity$444.9M+43.7%
Total assets$2.4B+45.6%

Cash flow

See full
Operating cash flow-$7.5M
CapEx-$22.5M-400%
Free cash flow-$30.1M

Valuation

See full
Market cap$8.43B-12.3%
Enterprise value$7.91B-16.6%
P/S5.9×-4.2×

Profitability

See full
Operating margin-19.8%-3.3pp
Net margin-17.8%-2.4pp
FCF margin-19.5%

Returns & leverage

See full
Return on equity-67.4%-16.0pp
Debt / equity0.2×0.0×
Current ratio3.3×+1.8×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Tempus AI, Inc.’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 4:01 PM EDT
Accession
0001193125-26-326083

FAQ

What is Tempus AI, Inc.'s stock-based comp?
Tempus AI, Inc. (TEM) reported stock-based comp of $54.12M in Q2 2026.
How has Tempus AI, Inc.'s stock-based comp changed year-over-year?
Tempus AI, Inc.'s stock-based comp increased by 141.0% year-over-year, from $22.46M to $54.12M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Tempus AI, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude